Make a note of our new URL: www.brjdermatol.org!
British Journal of Dermatology
An Official Journal of the British Association of Dermatologists
Edited by:
Dr Tanya O. Bleiker, Derby, UK
ISI Journal Citation Reports® Ranking: 2009: Dermatology: 4 / 48
Impact Factor: 4.26
Publishing a unique balance of basic science and clinical research
First choice in dermatology
- One of the top dermatology journals in the world: 2009 Impact Factor - 4.260
- High quality original research of instant importance: 2009 Immediacy Index - 0.727
Speed of Publication
- Rapid, robust peer review - average 15 days from submission to first decision
- Immediate 'preprint' publication upon article acceptance
- 70 days from receipt at publisher to print publication
- No page or colour charges
- Fully compliant with NIH Public Access Policy
International Readership
- Available in more than 5,000 medical and scientific libraries worldwide
- 80,000 page views per month
- Free e-alerts or RSS feeds for all registered users
- OnlineOpen: articles 'open access' upon payment of a one time author fee
Join the ranks of the world's best authors and submit your next paper to BJD
TopNews and Announcements
NEW - Online content now available back to Volume 4 (1892)
Back issues of this journal are now available online.
'Preprint' publication service
Further to acceptance in BJD, manuscripts are now published online immediately. AcceptedArticles are in the public domain, and citable by DOI
Articles published online ahead of print
Articles which have been fully copy-edited and peer-reviewed are published online through our Early View feature before the print edition of this journal is published
NIH Public Access Mandate
BJD is fully compliant with NIH Public Access Policy. Manuscripts will be deposited to PubMed Central (PMC) on authors' behalves. Click here for more information
Free access in the developing world
Free online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO)
TopHighlights
Top 10 Most Cited Articles from 2008*
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J.-H. Saurat, G. Stingl, L. Dubertret, et al.
Volume: 158 Issue: 3 Pages: 558-566 Published: MAR 2008
Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis
J.L. Abraham, C. Thakral, L. Skov, et al.
Volume: 158 Issue: 2 Pages: 273-280 Published: FEB 2008
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
C. Leonardi, A. Menter, T. Hamilton, et al.
Volume: 158 Issue: 5 Pages: 1107-1116 Published: MAY 2008
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
K.E. Nograles, L.C. Zaba, E. Guttman-Yassky, et al.
Volume: 159 Issue: 5 Pages: 1092-1102 Published: NOV 2008
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
T. Ruzicka, C.W. Lynde, G.B.E. Jemec, et al.
Volume: 158 Issue: 4 Pages: 808-817 Published: APR 2008
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy
C-H. Yang, W-C. Lin, C-K. Chuang, et al.
Volume: 158 Issue: 3 Pages: 592-596 Published: MAR 2008
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
D. Revicki, M.K. Willian, J.-H. Saurat, et al.
Volume: 158 Issue: 3 Pages: 549-557 Published: MAR 2008
Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
A.K. Brimhall, L.N. King, J.C. Licciardone, et al.
Volume: 159 Issue: 2 Pages: 274-285 Published: AUG 2008
Guidelines for topical photodynamic therapy: update
C.A. Morton, K.E. McKenna, L.E. Rhodes
Volume: 159 Issue: 6 Pages: 1245-1266 Published: DEC 2008
Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis
J.A. Kaye, L. Li, S.S. Jick
Volume: 159 Issue: 4 Pages: 895-902 Published: OCT 2008
*As per 15th April 2010
